Perri Tutelman remembers the young patient who, just weeks after an ovarian cancer diagnosis, sat in her office trembling—not only from the shock of illness, but from the fear of losing her chance to become a mother. "Will I ever have kids?" she asked. That moment, etched in Dr. Tutelman’s mind, captures the heart of a growing movement in cancer care: one that sees adolescents and young adults not just as patients, but as people navigating identity, dreams, and futures derailed by disease. Based at the University of Calgary, Dr. Tutelman is co-author of a new practice guide in the Canadian Medical Association Journal that urges clinicians to rethink how they support patients aged 15 to 39—a group long caught between pediatric and adult oncology systems.
This demographic faces a unique constellation of challenges. Cancer doesn’t just threaten their health—it disrupts education, relationships, careers, and milestones like starting a family. Yet for years, clinical guidance failed to reflect these realities. The new recommendations, shaped by both clinical expertise and lived experience, call for care that’s not only medical but deeply human. At the core is the understanding that a 22-year-old with leukemia has different emotional, social, and physical needs than a 65-year-old with the same diagnosis.
The guide outlines clear, actionable steps. Clinicians are advised to routinely screen for anxiety and depression—conditions that affect up to 35% of AYA patients—and to offer timely referrals for mental health support. They’re encouraged to use patient-centered language, avoiding dismissive phrases like "you’re too young to worry" and instead asking patients how they’d like to be addressed, including preferred names and pronouns. Fertility discussions should happen early, before treatment begins, so patients can explore options like egg or sperm freezing. And because most AYAs will live 50 to 60 years post-treatment, long-term follow-up care must be coordinated and consistent, monitoring for late effects like heart damage, secondary cancers, or cognitive changes.
Perhaps most powerfully, the guidance emphasizes identity-affirming care. For LGBTQ+ patients, racialized youth, or those from marginalized communities, trust in the health system can be fragile. Simple acts—like asking about pronouns or acknowledging cultural beliefs—can build that trust. As Dr. Tutelman writes, "Adolescents and young adults diagnosed with cancer are navigating far more than a diagnosis; they are often facing significant life transitions at the same time."
This shift isn’t just compassionate—it’s evidence-based. Studies show that AYA patients who receive coordinated, developmentally appropriate care have better outcomes, higher treatment adherence, and improved quality of life. As cancer survival rates rise, the focus must expand from simply surviving to truly thriving. For the tens of thousands of young people diagnosed each year in Canada and beyond, the future of care is not just longer—it’s more personal, more inclusive, and more hopeful.